Net income: $15.3 million, or $0.86 per diluted share (GAAP) in Q2 2025; adjusted to $16.6 million, or $0.94 per diluted ...

Novo Nordisk is a global diabetes and weight loss leader with strong long-term growth prospects. Read why NVO stock is a Strong Buy.

Abstract Summary Pharmacological enhancement of endoplasmic reticulum (ER) proteostasis is an attractive strategy to mitigate pathology linked to etiologically-diverse protein misfolding diseases.

Explore the BHEL Artisan Syllabus 2025, including exam pattern, post-wise syllabus, prep tips, and other details on this page ...

Spread the loveIntroduction In today’s digital age, computers have become an integral part of our daily lives. From the moment we wake up to check our smartphones to the complex systems managing our ...

Eversource Energy offers a 4.66% dividend yield with a 27-year history of increases, and is expected to outpace inflation through 2030. Read the full ES stock analysis.